Search filters

List of works by Atul Deodhar

A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis

scientific article published on 27 February 2020

Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities

scientific article published on 26 December 2018

Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study ⬇️

scientific article published on 13 December 2016

Elephant in the room

scientific article

GRAPPA 2015 Research and Education Project Reports

scientific article published in May 2016

Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies

scientific article published in 2023

Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study

scientific article published on 01 July 2020

Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

scientific article published on 30 April 2020

Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials

scientific article published on 23 January 2019

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial

scientific article published on 07 December 2020

Rebuttal letter to Dr. Fallahi's letter about our manuscript "Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities." Clin Rheumatol. 2018 Dec 26. https://doi.org/10.1007/s10067-018-4397-3

scientific article published on 12 March 2019

Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials

scientific article published on 23 November 2020

Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study

scientific article published on 31 August 2016

Secukinumab improves signs and symptoms of non-radiographic axial spondyloarthritis: primary results of a randomized controlled phase III study

scientific article published on 07 August 2020

Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials ⬇️

scientific article

The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis

scientific article

Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

scientific article published on 27 January 2017

Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature

scientific article published on 23 November 2020

Paulina is supported by:

About Paulina

Help